Company Information

Operating, investing and financing cash flows.

Cash Flow

SMS PHARMACEUTICALS LTD.

NSE Code: SMSPHARMAEQ
BSE Code: 532815
ISIN: INE812G01025
Industry: Pharmaceuticals

Financial Data

Cash Flow

All amounts are in ₹ crore unless stated otherwise.

Showing Standalone data

Five-year standalone Cash Flow for the selected company
Particulars	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR	AR	AR	AR	AR
FaceValue	1.00	1.00	1.00	1.00	1.00

Net Profit/Loss Before Extraordinary Items And Tax	116.27	93.32	66.33	5.55	68.65

Net CashFlow From Operating Activities	60.68	81.71	50.12	22.45	40.23
Net Cash Used In Investing Activities	-132.33	-123.44	-52.07	-29.69	-27.15
Net Cash Used From Financing Activities	76.03	47.08	30.68	-31.97	-6.92

Net Inc/Dec In Cash And Cash Equivalents	4.39	5.35	28.73	-39.21	6.16
Cash And Cash Equivalents Begin of Year	41.39	36.04	7.31	46.58	40.42
Cash And Cash Equivalents End Of Year	45.78	41.39	36.04	7.38	46.58

Five-year consolidated Cash Flow for the selected company
Particulars	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR	AR	AR	AR	AR
FaceValue	1.00	1.00	1.00	1.00	1.00

Net Profit/Loss Before Extraordinary Items And Tax	116.64	92.34	66.11	5.35	68.50

Net CashFlow From Operating Activities	59.22	81.71	50.12	22.45	40.23
Net Cash Used In Investing Activities	-130.78	-123.43	-52.07	-29.69	-27.15
Net Cash Used From Financing Activities	76.03	47.08	30.68	-31.97	-6.92

Net Inc/Dec In Cash And Cash Equivalents	4.48	5.36	28.73	-39.21	6.16
Cash And Cash Equivalents Begin of Year	41.40	36.04	7.31	46.58	40.42
Cash And Cash Equivalents End Of Year	45.88	41.40	36.04	7.38	46.58

Source: Financial statements as reported by the company.